mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity

mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity

Abstract Background Head and neck squamous cell carcinoma (HNSCC) has been rising in incidence primarily related to HPV‐associated oropharyngeal cancers. Novel molecular therapeutics are evolving with the mTOR pathway as a new target. Previous studies have shown variable outcomes with relatively low...

Full description

Bibliographic Details
Main Authors: Jaimin Patel, Shaun A. Nguyen, Besim Ogretmen, Jorge S. Gutkind, Cherie‐Ann Nathan, Terry Day
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Laryngoscope Investigative Otolaryngology
Subjects:
head and neck cancer
head and neck squamous cell carcinoma
mTOR inhibitors
oral cancer
oropharyngeal cancer
outcomes
Online Access:https://doi.org/10.1002/lio2.370

Internet

https://doi.org/10.1002/lio2.370

Similar Items